Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA
Mini Review
Maintenance aminoalkanoic acid catalyst Inhibitors Following Allogeneic hemopoietic cell Transplantation for Chronic Myelogenous Leukaemia
Author(s): Agostinho Machado*
It remains unknown whether or not the administration of aminoalkanoic acid enzyme inhibitors (TKIs) targeting BCR-ABL1 once allogeneic haematopoietic cell transplantation (HCT) is related to improved outcomes for patients with chronic Myelogenous leukaemia during this written account study, we have a tendency to analyzed clinical outcomes of 390 adult patients with CML UN agency underwent transplantation between and 2014 and received maintenance TKI following compared with no TKI maintenance as according to the middle for International Blood and Marrow Transplant analysis. All patients received TKI medical care before HCT. The bulk of patients had an .. View More»
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 